Endogen Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $53.6K

Endogen General Information

Description

Manufacturer of biomedical research products intended to investigate the underlying immunological mechanisms of diseases. The company's products include comprehensive lines of cytokine, T cell receptor, cell surface marker, and cell adhesion, enabling the life science industry to research cancer, AIDS, inflammation, and autoimmune disorders.

Contact Information

Website
www.endogen.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 8 Gill Street
  • Woburn, MA 01801
  • United States
+1 (617)
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 8 Gill Street
  • Woburn, MA 01801
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-1999 $53.6K Completed Generating Revenue
4. Grant 01-Jan-1998 Completed Generating Revenue
3. Grant 01-Jan-1997 Completed Generating Revenue
2. IPO 18-Sep-1995 $1.92M $1.92M Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Endogen’s complete valuation and funding history, request access »

Endogen Patents

Endogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2423288-A Elevated il-2 levels as indicators e.g., of allograft rejection Inactive 21-Aug-1987
EP-0329773-A1 Elevated il-2 levels as indicators e.g., of allograft rejection Inactive 21-Aug-1987
EP-0329773-A4 Elevated il-2 levels as indicators e.g., of allograft rejection Inactive 21-Aug-1987
CA-1335564-C Elevated il-2-levels as indicators, e.g. of allograft rejection Inactive 21-Aug-1987
GB-2220549-B Interleukin-2(il-2) levels as indicators eg,of allograft rejection,or of the presence or beneficial therapy of treatment for infections or autoimmune diseases Inactive 21-Aug-1987 G01N33/6869
To view Endogen’s complete patent history, request access »

Endogen FAQs

  • When was Endogen founded?

    Endogen was founded in 1983.

  • Where is Endogen headquartered?

    Endogen is headquartered in Woburn, MA.

  • What industry is Endogen in?

    Endogen’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Endogen a private or public company?

    Endogen is a Private company.

  • What is Endogen’s current revenue?

    The current revenue for Endogen is .

  • How much funding has Endogen raised over time?

    Endogen has raised $1.92M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process